Remove Compliance Remove COVID-19 Vaccine Remove FDA Remove US Department of Health and Human Services
article thumbnail

Health Provider News

Hall Render

NATIONAL 79 percent have positive outlook for senior living and care: NIC 12 key legal issues impacting health systems AHA: 94% of hospitals financially impacted by Change Healthcare’s cyberattack A conversation about the HHS plan on AI in health care A new kind of hospital is coming to rural America.

article thumbnail

Health Provider News

Hall Render

million patients Senate committee advances bill cutting hospital facility fees What Joint Commission, NQF’s affiliation means for hospitals Which health systems teamed up with Amazon, Google + Microsoft ALABAMA Alabama gets $3.6M in Stark law self disclosures: 3 things to know CMS’ staffing proposal will cost nursing homes $6.8B

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Health Provider News

Hall Render

in 2022, survey finds Senate votes to end COVID-19 national emergency Why are 600+ rural hospitals at risk of closing? in 2022, survey finds Senate votes to end COVID-19 national emergency Why are 600+ rural hospitals at risk of closing? What happens if it disappears?

article thumbnail

Hall Render’s Health Provider News – January 28, 2022

Hall Render

COVID-positive employees returning to work: 2 CEOs share their protocols. FDA halts use of antibody drugs that don’t work vs. omicron. Where Hospital Price Transparency Compliance Is Lagging. With a vaccine mandate looming, nursing homes face more staffing problems.

article thumbnail

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

Executive Health Resources, Inc. , Executive Health Resources, Inc. , United States Department of Health and Human Services , 58 F.4th In 2023, these include United States ex rel. Polansky v. UnitedHealthcare, Inc. , 3d 239 (Cal. Croda Inc. , 3d 191 (Del. C-8 Personal Injury Litigation , 87 F.4th

FDA 105